Oragenics Inc. Stock
Oragenics Inc. Stock
With 33 Sell predictions and only 1 Buy predictions Oragenics Inc. is one of the least favorite stocks of our community.
However, we have a potential of 5.32% for Oragenics Inc. as the target price of 8 € is above the current price of 7.6 €.
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | 1.400% | 8.209% | -7.643% | -50.000% | -45.896% | -86.190% | - |
| Larimar Therapeutics Inc. | - | 15.966% | 4.545% | 62.736% | 69.118% | -36.111% | -74.117% |
| Vaxart Inc. | -5.240% | 9.535% | -32.258% | -14.439% | 30.334% | -89.048% | - |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat